1887

oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - Strontium ranelate in the treatment of osteoporosis : editorial

 

Abstract

Extracted from text ... May 2006, Vol. 11, No. 1 JEMDSA Osteoporotic fractures are a common and important cause of disability and death worldwide. Antiresorptive agents like the bisphosphonates or the oestrogen analogues have been shown in large randomised controlled trials (RCTs) to significantly reduce the rate of osteoporotic fractures. These agents do not, however, abrogate fractures or the deranged skeletal microarchitecture that characterises osteoporosis; they only modestly and often transiently increase bone mineral density (BMD), and are not free of sideeffects. Moreover, since bone formation and resorption are usually tightly coupled, even in most types of osteoporosis, the decrease in bone resorption ..

Loading

Article metrics loading...

/content/m_jemdsa/11/1/EJC64124
2006-05-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error